Literature DB >> 9014855

Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis.

D T Leahy1, R Salman, H Mulcahy, K Sheahan, D P O'Donoghue, N A Parfrey.   

Abstract

Abnormalities in the p53 tumour suppressor gene and in the expression of its protein are common in colorectal carcinoma. The prognostic significance of these p53 abnormalities was studied in 66 patients with colorectal cancer, followed for more than 10 years. Single-strand conformation polymorphism (SSCP) analysis was used to detect alterations in exons 5-8 of the p53 gene. Paraffin sections were examined immunohistochemically for p53 overexpression with the monoclonal antibody DO-7 (Dako) both with and without microwave antigen retrieval. Abnormalities of the p53 gene were found in 41 per cent of cases by SSCP analysis. Outcome was unrelated to SSCP abnormalities (P = 0.19), except for the Dukes' A and B subgroup, where decreased survival was found in cases with abnormal SSCP (P = 0.01). Overexpression of p53 protein was seen by immunohistochemistry in 47 per cent of cases without, and in 52 per cent of cases with microwave antigen retrieval. Immunohistochemical overexpression of p53 protein either with or without microwave antigen retrieval was an independent prognostic indicator of poor survival. These results suggest that for routine purposes, immunohistochemical detection of the p53 protein product may be more useful than SSCP analysis of the encoding p53 gene in identifying those at high risk of colorectal cancer recurrence and death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014855     DOI: 10.1002/(SICI)1096-9896(199612)180:4<364::AID-PATH683>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

Review 1.  The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

2.  Molecular validation of the modified Vienna classification of colorectal tumors.

Authors:  Tamotsu Sugai; Wataru Habano; Noriyuki Uesugi; Yu-Fei Jiao; Shin-ichi Nakamura; Kimihiko Sato; Toshimi Chiba; Motohiro Ishii
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

3.  Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.

Authors:  David S Williams; Dmitri Mouradov; Clare Browne; Michelle Palmieri; Meg J Elliott; Rebecca Nightingale; Catherine G Fang; Rita Li; John M Mariadason; Ian Faragher; Ian T Jones; Leonid Churilov; Niall C Tebbutt; Peter Gibbs; Oliver M Sieber
Journal:  Mod Pathol       Date:  2019-08-30       Impact factor: 7.842

4.  Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.

Authors:  P Kanavaros; K Stefanaki; K Valassiadou; J Vlachonikolis; M Mavromanolakis; M Vlychou; S Kakolyris; V Gorgoulis; M Tzardi; V Georgoulias
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

5.  c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Authors:  A Biroccio; B Benassi; I D'Agnano; C D'Angelo; S Buglioni; M Mottolese; A Ricciotti; G Citro; M Cosimelli; R G Ramsay; B Calabretta; G Zupi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

Review 7.  Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature.

Authors:  B Klump; O Nehls; T Okech; C-J Hsieh; V Gaco; F S Gittinger; M Sarbia; F Borchard; A Greschniok; H H Gruenagel; R Porschen; M Gregor
Journal:  Int J Colorectal Dis       Date:  2003-06-21       Impact factor: 2.571

8.  Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression.

Authors:  Florence Jourdan; Nicole Sebbagh; Eva Comperat; Najat Mourra; Antoine Flahault; Sylviane Olschwang; Alex Duval; Richard Hamelin; Jean-François Flejou
Journal:  Virchows Arch       Date:  2003-06-07       Impact factor: 4.064

9.  The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer.

Authors:  Zhenyu He; Chuanbing Shi; Hao Wen; Fanglong Li; Baolin Wang; Jie Wang
Journal:  J Biomed Res       Date:  2010-01

10.  Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.

Authors:  Rahim Golmohammadi; Mohammad J Namazi; Mehdi Nikbakht; Mohammad Salehi; Mohammad H Derakhshan
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.